RecruitingNCT06764524
Hairy Cell Leukemia: Harnessing the Full Power of Extracellular Vesicles to Improve Patient Care Management
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
50 participants
Start Date
Dec 5, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Check whether patients with Hairy Cell Leukemia (HCL) of different status (at diagnosis, in complete remission \> 2 years or relapsed requiring therapy) have a 'signature' of altered immunity based on extracellular vesicles (EV)
Eligibility
Min Age: 18 Years
Inclusion Criteria6
- WHO2022-defined diagnosis of Hairy Cell Leukemia.
- age ≥18 years.
- signed informed consent.
- age ≥18 years.
- Volunteers in general good health, free from any disease or serious illness.
- Signed informed consent.
Exclusion Criteria1
- \- None
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06764524
Related Trials
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
NCT010873331 location
Decoding the Extracellular Vesicles-driven Communication in the Microenvironment of Hairy Cell Leukemia to Improve Patient Care Management
NCT067746773 locations